Peritoneal mesothelioma is a rare but incurable cancer arising from the membranes of the abdominal cavity. It is associated with asbestos exposure.
The University of Maryland Marlene and Stewart Greenebaum Cancer Center (UMGCC) is an internationally recognized center specializing in diagnosis, treatment, and research of mesothelioma and other asbestos-related diseases. Dr. Richard Alexander, professor of surgery and associate chairman for clinical research, is recognized as a leading expert in the treatment and research of this disease. Almost 1 in 10 people diagnosed with peritoneal mesothelioma in the U.S. come to the University of Maryland for consultation or treatment.
Important research efforts are now underway at UMGCC to discover new and more effective treatments.
A recent major discovery in Dr. Alexander’s laboratory showed that specific genes and proteins drive the growth of peritoneal mesothelioma. This breakthrough discovery, published in January, 2011 in Cancer, is acknowledged as one of the biggest advances in peritoneal mesothelioma research in a decade, and will be the foundation for new and more effective treatments for patients with mesothelioma.